As trial results rolled in, that mismatch began to put a strain on Kirschs relationship with the funds advisory board. Dosage there is 30mg once a day. It is currently approved for treatment of depression and obsessive compulsive disorder (OCD). Now they turn to Rust. I believe they made the right decision and we should be rushing to follow their advice. The only way to do that is to treat them as early as possible with a drug that prevents hospitalization and death. There were no studies reported out so far where fluvoxamine made things worse or neutral. ALWAYS check with your doctor and report any medications you are taking before or plan to take after you start taking fluvoxamine. In some cases, youd want to taper down the dosage. Weve known it works since August 24, 2020. None of this would really matter if Kirschs views on vaccinations were private, or shared with a limited audience. All this was known back in January 2021 when a key opinion leader panel of experts from NIH, CDC, FDA, academia, and journal editors voted by over 2:1 to recommend that fluvoxamine be recommended to physicians to discuss with patients. But they will refuse to give it to you even after being proven in a Phase 3 trial that was approved by the WHO. NIH doesnt want you to get the drug since it would compete with Molnupiravir, so fluvoxamine will never make the NIH guidelines. Jan 17. Another is to identify an asteroid that is going to hit the planet.. The NIH never did a risk benefit analysis of this drug. Fluoxetine is just as effective. Hes very convincing. Compulsive fiddling with your mask? There are 4 outpatient studies that have been done (2 at WashU (see. After two weeks (since it was a tight knit community, everyone could see what was happening to the two groups), every track worker who got sick with COVID, demanded the drug. Hes spending his own money to do what he thinks is right. Fluvoxamine is way better than Molnupiravir, but the NIH doesnt approve drugs on effectiveness. Yeah, its possible, he told mehe also says that he has regularly seen Kirsch manipulate evidence so that it seems to support claims that are, in reality, baseless. In fact, he was unwittingly the source for one of Kirschs figures. Ive used it personally at 50mg twice a day and experience no adverse events at all. It was approved by the FDA in 1994 and has been used in millions of patients worldwide. Dr. Seftel is an NIH-funded researcher and an NIH reviewer. There is an executive summary below, but the most important thing is that top infectious disease docs who have looked at all the evidence (including the two clinical trial results) believe the effect size is 75% or more in reducing the hospitalization rate. Think about it Molnupiravir has a 50% risk reduction whereas fluvxoamine is over 90%. I have all of these on hand and I load up on vitamin D3 every day. If not, they should at least acknowledge that fluvoxamine might be helpful by at least listing it as a possibility. Please read and agree to the disclaimer before watching this video.. Steve Kirsch On COVID Early Treatment and CensorshipSteve Kirsch is an entrepreneur and . BOMBSHELL: Top biostats professor admits we have NO CLUE # of people KILLED by COVID vaccines, he wrote. Steve Kirsch -Executive Director at COVID-19 Early Treatment Fund Ivermection study - One .2mg/kg dose a week for prevention "100% success rate whereas those doctors taking placebo had a 59%% infection rate not a typo 237 of 400 docs on placebo got infected vs. 800 docs on Ivermectin none got infected" Antivirals Why the FDA should grant an EUA for fluvoxamine immediately, Links to evidence about fluvoxamine including the public data repository, Here's the first one: But the potential upsides. The medical community doesnt care about saving lives. The data we have today with just 2 clinical trials (RCT and confirmatory RWE) is compelling. Doctors are afraid that even with a 37-year safety record of this drug, that something will go terribly wrong and they will be blamed. After several failed attempts to stop the progression of his disease, he designed his own protocol for chemotherapy and doctor-shopped to find an oncologist who would give it to him. . The web value rate of skirsch.io is 2 . Some countries dont have fluvoxamine so this is the alternative. Although the average effect size is 100% with a p-value of <.0001, The Fisher exact test on the combined data suggests that there is a 95% chance that the effect size is at least a 75% reduction in hospitalization rate. They never make things worse so are safe to try. But they dont want their names used. Completely avoid caffeine, alcohol, tylenol, and benadryl. NIH and WHO refuse to acknowledge it works since it will cause vaccine hesitancy if it is known that there is a drug that turns COVID into a mild disease. skirsch.io. Author Affiliations . Kirsch and his group received a fresh wave of attention off hopeful trials of the antidepressant fluvoxamine, which ultimately won him a spot on 60 Minutes in March. Try refreshing this page and updating them one Get your prescription in advance of getting COVID. He started a covid-19 vaccine company. There are two ways Ive discovered that I may be able to save the world, he told an IEEE Spectrum reporter in 2000. We report a real-world experience using fluvoxamine for coronavirus disease 19 (COVID-19) in a prospective cohort in the setting of a mass outbreak. Your best bet is to. Discover special offers, top stories, Hes refused to accept the results of a hydroxychloroquine trial that showed the drug had no value in treating covid, for instance, instead blaming investigators for poor study design and statistical errors. Fluvoxamine has a 40 year safety track record. He has been a medical philanthropist for more than 20 years. He applied the drug to a large COVID outbreak at Golden Gate Fields just days after the Lenze trial was published. No more. Most recent articles first. Think about it Molnupiravir has a 50% risk reduction whereas fluvxoamine is over 90%. The NIH wrote a bullshit rejection because the FDA told them not to approve it. Kirsch told me that meta-analyses are a higher level of evidence than randomized controlled trials. When I responded that meta-analyses are only as good as the data they are based on, he said Id like to understand your source on that, because I cant find a source that says a phase 3 trial is greater evidence than a meta-analysis., When you characterize me, you need to say that Steve Kirsch doesn't go with majority votes on interpreting data.. But they will refuse to give it to you even after being proven in a Phase 3 trial that was approved by the WHO. He was recently featured on 60 Minutes, . That is when the phase 2 results were published. It will be months before enrollments are complete. Seftel was able to duplicate the 100% protection from hospitalization and death in the treatment group, vs. a 12.5% hospitalization/death rate for the No treatment group. Note that some of these articles are inaccurate. No long haul symptoms if you start the drug ASAP after first symptoms. They all promised me when fluvoxamine passed Phase 3 trials, nearly everyone would use it. We could have saved a lot of lives. He immediately tweeted an offer to give anyone $1 million if they could win a debate with him about vaccine deaths. The group who declined the drug were very sick with 12.5% requiring hospitalization and one died. CETF Founder Steve Kirsch discusses why we can't wait for a COVID-19 vaccine, the importance of researching existing drugs now, and our work to raise funds for outpatient trials to identify effective . Entrepreneur Steve Kirsch who holds an early patent for the optical mouse decided to get involved in treating Covid. When I asked him why so many experts in the field disagreed with him, he alleged there were effortseither malicious or negligentto suppress evidence of cheap, effective covid treatments. Both of them encouraged anyone reading this article to get vaccinated. We should not wait for the Phase 3 RCT. fluvoxamine The fast, easy, safe, simple, low cost treatment for COVID that has worked 100% of the time to prevent hospitalization that nobody wants to talk about We now have a viable solution to reduce COVID hospitalization and mortality; Read More fluvoxamine Got COVID? Patients should be advised to limit/avoid the use of caffeine while on the drug since fluvoxamine extends the half life of caffeine (making you super wired). 9th International Congress on Psychopharmacology 5th International Symposium on Child and Adolescent Psychopharmacology Dr. Joe Ladapo wrote a brilliant op-ed in the Wall Street Journal, "Too much caution is killing COVID patients." Kirsch did a lot of things right when he set up CETF. You will be wired for 24 hours if you dont heed my advice. Note: normally I have lots of hyperlinks to all the sources, but Im pressed for time. The documents in the data room discuss all eight (you'll need access to the restricted area to see the presentation on all 8). It is an amazing drug and is a very simple safe way to avoid long-haul COVID symptoms. Where did it go wrong. The drug was widely prescribed as a covid treatment for much of 2020, based on anecdotes and flawed studies. But a panel of key opinion leaders from the NIH, CDC . He has a history of giving away some of his millions to good causes, and when COVID-19 began. It was tested in. They knew in advance it was coming and on the day the paper was published they ignored it entirely. At the end of May this year, Siliciano emailed the other advisors to say that Kirsch had gone off the deep end and he was cutting ties. The medical community did nothing (with a few exceptions like Dr. Seftel). My crime? Once the Phase 2 result came out, it should have been embraced by doctors. In every case we are aware of, the drug was successful in reversing COVID symptoms, generally in 3 days or less. I have never heard of a case it didn't work. My favorite dosage is 50mg twice a day for 14 days. So why would we wait when lives are being lost? In a recent post, discussing claims Kirsch made during a three-minute comment at an FDA public forum, Morris wrote: In spite of many pages of writing and claims of over a dozen independent analyses verifying their results, their evidence falls far short of substantiating these dramatic conclusions, including a claim that vaccines have caused >250K excess deaths in the USA.. For example, tylenol+caffeine+fluvoxamine can lead to serotonin syndrome. The U of M's study focused on three common drugs: ivermectin, metformin, and fluvoxamine. Thats why they didnt even fund the fluvoxamine trial, he told me. It is perhaps the greatest unnecessary loss of life in American history. Their willingness to lie did. If you start 5 days after symptoms, all bets are off. They were all given the drug soon after symptoms and the placebo group was pure in that they were not taking any COVID drugs. I wanted to get the article out before my flight left. We could have saved a lot of lives. To date, the #1 drug with the most evidence to make a significant difference, without any doubt, is fluvoxamine.